How Syngenta Group’s Innovation is Powering Supply Chains

Syngenta Group continues to reinforce its global footprint and supply chain resilience, delivering US$28.4bn in full-year sales in 2025.

Full-year sales were down 1%, with EBITDA up 13% to US$4.4bn and margins improving to 15.4%, reflecting strong global performance.

The results highlight Syngenta’s ability to maintain high-value, innovation-led operations in an industry challenged by commodity price volatility, geopolitical uncertainty and disrupted trade.

Syngenta has also strengthened its supply chains by embedding advanced technology and data-driven processes.

High-impact artificial intelligence lighthouse projects were expanded, designed to unlock measurable business value and create scalable models for transformation across operations.

Biologicals continued double-digit growth, responding to rising demand for bio-controls, bio-stimulants and nutrient-efficiency products.

A new production facility in Orangeburg, South Carolina, complements manufacturing sites in Brazil, Italy, India and Norway, reinforcing the Group’s ability to deliver products efficiently across multiple regions.

Corporate leadership changes in 2026 included Nelson Jiang’s appointment as Group CFO, bringing more than 30 years of financial leadership experience, and Hengde Qin’s move into a new Chief Operating Officer role to oversee strategy execution and corporate functions, enhancing organisational alignment globally.

Crop Protection sales reached US$13.7bn, up 4%, driven by high-value product innovations and strong regional execution.

North America led growth with a 10% increase, while Europe and Asia, Middle East and Africa excluding China rose 5%. China grew 8%, while Brazil and Latin America faced pricing pressures.

Seeds sales rose 2% to US$4.8bn. Field crops performed strongly in the Southern Hemisphere, while vegetable sales grew 5%.

New corn hybrids and soybean varieties strengthened market share in Brazil and Argentina.

Global infrastructure investments included seed health labs and AI-driven breeding initiatives to increase efficiency and accelerate innovation.

Syngenta Group China recorded US$8.3bn in sales, down 10% due to strategic reductions in grain trading.

Seeds and branded formulations grew, while a new crop protection formulation plant in Nantong came online. The Group also completed the spin-off of Sinofert Holdings, ending fertilizer consolidation from January 2026.

ADAMA reported US$4.1bn in 2025 sales, down 2% amid challenging markets for post-patent active ingredients. Its strategic transformation plan launched in 2024 delivered EBITDA growth and margin improvements for the sixth consecutive quarter.

ADAMA streamlined operations to focus on key geographies and off-patent molecules enhanced by proprietary formulation technologies.

North America sales rose 11%, while Europe, Africa, Latin America and Asia Pacific declined in line with a shift toward higher-quality business.

ADAMA’s performance underscores Syngenta Group’s global strategy of operational discipline, innovation and resilient supply chains.